The association between serotonin transporter gene promotor polymorphism (5-HTTLPR) and elemental mercury exposure on mood and behavior in humans

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 15, 2010, Pages 1003-1020

  Echeverria, Diana ^a,b   Woods, James S ^b   Heyer, Nicholas J ^a   Martin, Michael D ^b   Rohlman, Dianne S ^c   Farin, Federico M ^b   Li, Tingting ^b  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BEHAVIOR; DENTAL ASSISTANT; DENTIST; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MERCURIALISM; MOOD; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; URINE LEVEL;

ADULT; AFFECT; BEHAVIOR; DENTAL ASSISTANTS; DENTISTRY; FEMALE; GENOTYPE; HAND; HUMANS; MALE; MEMORY; MERCURY; MERCURY POISONING, NERVOUS SYSTEM; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; OCCUPATIONAL EXPOSURE; REGRESSION ANALYSIS; SENSATION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SOCIOECONOMIC FACTORS; VIBRATION; VISUAL ACUITY; WECHSLER SCALES;

EID: 77953254923     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903566591     Document Type: Article

References (53)

1. Amler, R. W., Anger, W. K., and Sizemore, O. J. 1995. Adult Environmental Neurobehavioral Test Battery (AENTB). Atlanta, GA: U.S. Department of Health and Human Services, Agency for Toxic Substances and Disease Registry.
2. Anger, W. K. 1985. Neurobehavioral tests used in NIOSH supported worksite studies, 1973-1983. Neurotoxicol. Teratol. 7:359-368.
3. Anger, W.K., Sizemore, O.J. Grossmann, S.J., Glasser, J.A. Letz, R., and Bowler, R. 1997. Human neurobehavioral research methods: Impact of subject variables. Environ Res. 73:18-41.
4. Ansorge, M. S., Zhoum M., Lira, A., Hen, R., and Gingrich, J. A. 2004. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306:879-881.
5. Baca-Garcia, E., Vaquero, C., Diaz-Sastre, C., Saiz-Ruiz, J., Fernandez-Piqueras, J., and de Leon, J. 2002. A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 26:692-695.
6. Beck, A. T. 1998. Beck's Depression Index. San Antonio, TX: The Psychological Corporation, Harcourt Brace and Company.
7. Brown, B., Sherbenou, R., and Johnsen, S. 1997. Test of Non-verbal Intelligence TONI-3. Austin, TX: Pro-ed.
8. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., and Poulton, R. 2003. Influence of life stress on depression: Modulation by a polymorphism in the 5-HTT gene. Science 301:386-389.
9. Chong, S.-A., Lee, W.-L., Tan, C.-H., Tay, A. H.-N., Chan, A. O.-M., and Tan, E.-C. 2000. Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res. 97:101-106.
10. Clarkson, T. W. 2002. Three modern faces of mercury. Environ. Health Perspect. 110(suppl. 1):11-23.
11. Cohen, J., and Cohen, P. 1975. Applied multiple regression/correlation analyses for the behavioral sciences. New York: Wiley.
12. Derogatis, L. R. 1977. The SCL-90 Manual I: Scoring, administration and procedures for the SCL-90. Baltimore, MD: Clinical Psychometric Research.
13. Echeverria, D., Aposhian, H. V., Woods, J. S., Heyer, N. J., Aposhian, M. M., Bittner, A. C., Mahurin, R. K., and Cianciola, M. 1998. Neurobehavioral effects from exposure to dental amalgam Hg?: New distinctions between recent exposure and Hg body burden. FASEB J. 12:971-980.
14. Echeverria, D., Heyer, N. J., Martin, M. D., Naleway, C. A., Woods, J. S., and Bittner, A. C. 1995. Behavioral effects of low-level exposure to Hgamong dentists. Neurotoxicol. Teratol. 17:161-168.
15. Echeverria, D., Heyer, N. J., Bittner, A. C., Jr., Rohlman, D., and Woods, J. S. 2002. Test-retest reliability and factor stability of the Behavioral Evaluation for Epidemiology Studies test battery. Percept. Motor Skills 95:845-867.
16. Echeverria, D., Woods, J. S., Heyer, N. J., Rohlman, D. S., Farin, F. M., Bittner, A. C., Jr., Li, T., and Garabedian, C. C. 2005. Chronic low-level mercury exposure, BDNF polymorphism, and associations with memory and motor function. Neurotoxicol. Teratol. 27:781-796.
17. Echeverria, D., Woods, J. S., Heyer, N. J., Rohlman, D., Farin, F. M., Li, T., and Garabedian, C. C. 2006. The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans. Neurotoxicol. Teratol. 28:39-48.
18. Factor-Litvak, P., Hasselgren, G., Jacobs, D., Begg, M., Kline, J., Geier, J., Mervish, N., Schoenholtz, S., and Graziano, J. 2003. Mercury derived from dental amalgams and neuropsychologic function. Environ. Health Perspect. 111:719-723.
19. Gaspar, P., Cases, O., and Maroteaux, L. 2003. The developmental role of serotonin: News from mouse molecular genetics. Nature Rev. Neurosci. 4:1002-1012.
20. Gingrich, J. A., Ansorge, M. S., Merker, R., Weisstaub, N., and Zhou, M. 2003. New lessons from knockout mice: The role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. CNS Spectrosc. 8:572-577.
21. Gerstner, H. B., and Huff, J. E. 1977. Clinical toxicology of mercury. J. Toxicol. Environ. Health 2:491-526.
22. Hand Motor Steadiness Battery.2000. Purdue, IN: Lafayette Instrument Company.
23. Heyer, N. J., Echeverria, D., Bittner, A. C., Jr., Farin, F. M., Garabedian, C. C., and Woods, J. S. 2004. Chronic low-level mercury exposure, BDNF polymorphism, and associations with self-reported symptoms and mood. Toxicol. Sci. 81:354-363.
24. Heyer, N. J., Echeverria, D., Farin, F. M., and Woods, J. S. 2008. The association between serotonin transporter gene promoter polymorphism (5-HTTLPR), self-reported symptoms, and dental mercury exposure. J. Toxicol. Environ. Health A 71:1318-1326.
25. Heyer, N. J., Echeverria, D., Martin, M. D., Farin, F. M., and Woods, J. S. 2009. Catechol-Omethyltransferase (COMT) Val158Met functional polymorphism, dental mercury exposure, and self-reported symptoms and mood. J. Toxicol. Environ. Health A 72:599-609.
26. Ito, K., Yoshida, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., Suzuki, T., Ohkubo, T., Sugawara, K., and Otani, K. 2002. A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine. Psychiatry Res. 111:223-235.
27. Kahneman, D. 1973. Attention and effort. Upper Saddle River, NJ: Pearson Education.
28. Kim, D. K., Lim, S. W., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., and Carroll, B. J. 2000. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11:215-219.
29. Kingman, A., Albertini, T., and Brown, L. J. 1998. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J. Dent. Res. 77:461-471.
30. Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Breenberg, B. D., Petri, S., Benjamin, J., Muller, C. R., Hamer, D. H., and Murphy, D. L. 1996. Association of anxiety-related trait with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
31. Lesch, K. P., Jatzke, S., Meyer, J., Stöber, G., Okladnova, O., Mössner, R., and Riederer, P. 1999. Mosaicism for a serotonin transporter gene promoter-associated deletion: Decreased recombination in depression. J. Neural Transmit. 106:1223-1230.
32. Letz, R. 1993. The NES2 user's manual. Winchester, MA: Neurobehavioral Systems.
33. Lin, P.-Y. and Tsai, G. 2004. Association between serotonin transporter gene promoter polymorphism and suicide: Results of a metaanalysis. Biol. Psychiatry 55:1023-1030.
34. McNair, D. M., Lorr, M., and Droppleman, L. F. 1971. EITS manual-Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
35. Naleway, C., Sakaguchi. R., Mitchell, E., Muller, T., Ayer, W. A., and Hefferren, J. J. 1985. Urinary mercury levels in U.S. dentists, 1975-1983: Review of Health Assessment Program. J. Am. Dent. Assoc., 111:37-42.
36. Optec 2000/25000 Vision Testing System. 1998. Tempe, AZ: Veatch Opthalmic Instruments.
37. Pingree, S. D., Simmonds, P. L., and Woods, J. S. 2001. Effects of 2,3-dimercapto-1-propane-sulfonate (DMPS) on tissue and urine mercury (Hg) and porphyrin levels in methyl mercury-exposed rats. Toxicol. Sci. 62:224-233.
38. Pollock, B. G., Ferrell, R. E., Mulsant, B. H., Mazumdar, S., Miller, M., Sweet, R. A., Davis, S., Kirshner, M. A., Houck, P. R., Stack, J. A., Reynolds, C. F., and Kupfer, D. J. 2000. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23:5: 587-590.
39. Posner, M. I., and Petersen, S. E. 1990. The attention system of the human brain. Annu. Rev. Neurosci. 13:25-42.
40. Ritchie, K. A., Gilmour, W. H., Macdonald, E. B., Burke, F. J. T., McGowan, D. A., Dale, I. M., Hammersley, R., Hamilton, R. M., Binnie, V., and Collington, D. 2002. Health and neuropsychological functioning of dentists exposed to mercury. J. Occup. Environ. Med. 59:287-293.
41. Smargiassi, A., Bergamaschi, E., Mutti, A., and Cella, M. T. 1998. Predictive validity of the Q16 questionnaire: A comparison between reported symptoms and neurobehavioral tests. Neurotoxicology 19:703-708.
42. Stimpson, N., Agrawal, N., and Lewis, G. 2002. Randomized controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br. J. Psychiatry 181: 284-294.
43. Vibratron II Vibration Sensitivity Tester. 1998. NJ: Physitemp Instruments, Seattle, Washington.
44. Vroom, F. G., and Greer, M. 1972. Mercury vapor intoxication. Brain 95:305-318.
45. Wechsler, D. 1945. A standardized memory scale for clinical use. J. Psychol. 19:87-95.
46. White, R. F., Feldman, R. G., and Proctor, S. P. 1992. Neurobehavioral effects of toxic exposures. In Clinical syndromes in adult neuropsychology: The practioner's handbook, ed. R. F. White, pp. 1-51. Amsterdam: Elsevier
47. White, R. F., and Proctor, S. P. 1992. Research and clinical criteria for development of neurobehavioral test batteries. J. Occup. Med. 34:140-148.
48. Wilkinson, G. S. 1993. Wide Range Achievement Test-Reading, 3rd ed. Wilmington, DE: Jastak Associates.
49. Woods, J. S., Echeverria, D., Heyer, N. J., Simmonds, P. L., Wilkerson, J., and Farin, F. M. 2005. The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans. Toxicol. Appl. Pharmacol. 126: 113-120.
50. World Health Organization. 1986. Operational guide for the WHO Neurobehavioral Core Test Battery, Draft 25.5. Geneva: Office of Occupational Health.
51. Yoshida, K., Ito, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., Suzuki, T., Ohkubo, T., Sugawara, K., and Otani, K. 2002. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 26: 383-386.
52. Zalsman, G., Huang, Y., Oquendo, M. A., Burke, A. K., Hu, X., Brent, D. A., Ellis, S. P., Goldman, D., and Mann, J. J. 2006. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life event and severity of depression. Am. J. Psychiatry 163:1588-1593.
53. Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M., and Smeraldi, E. 2000. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J. Clin. Psychopharmacol. 20: 105-107.